Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$50.45 - $72.82 $28,958 - $41,798
574 New
574 $30,000
Q3 2022

Nov 14, 2022

SELL
$70.55 - $111.58 $17,637 - $27,895
-250 Reduced 3.34%
7,238 $511,000
Q2 2022

Aug 15, 2022

BUY
$50.24 - $80.48 $6,631 - $10,623
132 Added 1.79%
7,488 $531,000
Q1 2022

May 16, 2022

BUY
$57.98 - $93.5 $411,078 - $662,915
7,090 Added 2665.41%
7,356 $588,000
Q4 2021

Feb 14, 2022

BUY
$88.02 - $127.79 $88 - $127
1 Added 0.38%
266 $24,000
Q3 2021

Nov 15, 2021

BUY
$122.75 - $162.68 $491 - $650
4 Added 1.53%
265 $34,000
Q2 2021

Aug 16, 2021

BUY
$105.76 - $154.96 $3,067 - $4,493
29 Added 12.5%
261 $40,000
Q1 2021

May 17, 2021

BUY
$78.5 - $126.48 $1,413 - $2,276
18 Added 8.41%
232 $24,000
Q4 2020

Feb 16, 2021

BUY
$55.93 - $82.78 $111 - $165
2 Added 0.94%
214 $17,000
Q2 2020

Aug 14, 2020

BUY
$29.15 - $61.54 $174 - $369
6 Added 2.91%
212 $13,000
Q1 2020

May 15, 2020

BUY
$25.01 - $42.4 $5,152 - $8,734
206 New
206 $7,000
Q3 2019

Nov 14, 2019

SELL
$25.78 - $34.8 $2.51 Million - $3.39 Million
-97,513 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$23.08 - $37.01 $515,976 - $827,395
-22,356 Reduced 18.65%
97,513 $2.87 Million
Q1 2019

May 17, 2019

BUY
$27.81 - $40.78 $2.69 Million - $3.95 Million
96,768 Added 418.89%
119,869 $4.1 Million
Q4 2018

Feb 14, 2019

SELL
$28.91 - $50.0 $4,683 - $8,100
-162 Reduced 0.7%
23,101 $737,000
Q3 2018

Oct 30, 2018

BUY
$30.85 - $50.65 $717,663 - $1.18 Million
23,263 New
23,263 $1.12 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.15B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.